News & Articles
eTheRNA immunotherapies and Ghent University announce mRNA delivery collaboration and license agreement
The novel lipid nanoparticles for mRNA delivery will enhance thermostability, biodegradability and safety, paving the way for new off-the-shelf therapies
Ortho Clinical Diagnostics’ quantitative COVID-19 IgG antibody test first to receive FDA EUA
VITROS Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies
Mixed Oxford/Pfizer vaccine schedule provides 'robust' COVID-19 protection
Mixed schedules involving Pfizer-BioNTech and Oxford-AstraZeneca generate strong immune response against SARS-CoV2 spike IgG protein
Gyros Protein Technologies and Cygnus Technologies collaborate to support bioprocess impurity analytics
The Collaboration is poised to deliver a range of ready-to-use bioprocess impurity reagent sets
Thermo Fisher Scientific and UC Davis launch center of excellence in clinical metabolomics
The center will develop new technologies and reproducible analytical techniques to support rapid, cost-effective clinical research
Univercells Technologies and VectorBuilder announce strategic partnership for optimized custom viral vector production
Univercells Technologies will work with VectorBuilder to develop and optimize NevoLine Upstream platform and scale-X bioreactors for the production of custom viral vectors
Engineered yeast could expand biofuels’ reach
By making the microbes more tolerant to toxic byproducts, researchers show they can use a wider range of feedstocks, beyond corn
Park Systems announces Park FX40, the autonomous AFM with built-in intelligence
The new AFM offers an overhaul in functionality while retaining the same basic design elements
Engineers at Massachusetts Institute of Technology (MIT) design synthetic biology circuits that can respond within seconds
MIT engineers design the first synthetic circuit that consists entirely of fast, reversible protein-protein interactions
WITec GmbH joins Oxford Instruments plc
Quanterix’ Simoa technology powers largest and most diverse global investigation of plasma neurofilament light’s role in dementia diagnosis
The ultra-sensitive biomarker platform evaluates plasma neurofilament light’s utility across 13 neurodegenerative disorders, Down syndrome and depression
New study shows significant inflammatory responses after meals
Acute and prolonged food-induced inflammation can increase the predicted risk of developing cardiometabolic diseases like cardiovascular disease, new research has shown.